Deciphering transcription dysregulation in FSH muscular dystrophy

Journal of Human Genetics

Volumn 57, Issue 8, 2012, Pages 477-484

  Ehrlich, Melanie ^a   Lacey, Michelle ^b  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Tulane University   (United States)

Author keywords

expression profiling; FSHD; muscular dystrophy; myogenesis

Indexed keywords

DUX4 PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

CELL LINEAGE; CELL NUCLEUS; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; GENE EXPRESSION; HUMAN; MYOBLAST; MYOTUBE; NONHUMAN; OSCILLATORY POTENTIAL; PATHOGENESIS; PHENOTYPE; PROTEIN DOMAIN; PROTEIN EXPRESSION; REVIEW; TRANSCRIPTION REGULATION;

GENE EXPRESSION REGULATION; GENES, DOMINANT; HOMEODOMAIN PROTEINS; HUMANS; MUSCLE FIBERS, SKELETAL; MUSCLES; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; MYOBLASTS;

EID: 84865679748     PISSN: 14345161     EISSN: 1435232X     Source Type: Journal    
DOI: 10.1038/jhg.2012.74     Document Type: Review

References (100)

1. Hewitt, J. E., Lyle, R., Clark, L. N., Valleley, E. M., Wright, T. J., Wijmenga, C. et al. Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy. Hum. Mol. Genet. 3, 1287-1295 (1994).
2. Matsumura, T., Goto, K., Yamanaka, G., Lee, J., Zhang, C., Hayashi, Y. K. et al. Chromosome 4q;10q translocations; comparison with different ethnic populations and FSHD patients. BMC Neurol. 2, 7 (2002).
3. Lemmers, R. J., van der Vliet, P. J., van der Gaag, K. J., Zuniga, S., Frants, R. R., de Knijff, P. et al. Worldwide population analysis of the 4q and 10q subtelomeres Identifies only four discrete interchromosomal sequence transfers in human evolution. Am. J. Hum. Genet. 86, 364-377 (2010).
4. Kowaljow, V., Marcowycz, A., Ansseau, E., Conde, C. B., Sauvage, S., Matteotti, C. et al. The DUX4 gene at the FSHD1A locus encodes a pro-apoptotic protein. Neuromuscul. Disord. 17, 611-623 (2007).
5. Lemmers, R. J., van der Vliet, P. J., Klooster, R., Sacconi, S., Camano, P., Dauwerse, J. G. et al. A unifying genetic model for facioscapulohumeral muscular dystrophy. Science 329, 1650-1653 (2010).
6. Snider, L., Geng, L. N., Lemmers, R. J., Kyba, M., Ware, C. B., Nelson, A. M. et al. Facioscapulohumeral dystrophy: incomplete suppression of a retrotransposed gene. PLoS Genet. 6, e1001181 (2010).
7. Tawil, R. Facioscapulohumeral muscular dystrophy. Neurotherapeutics 5, 601-606 (2008).
8. Scionti, I., Fabbri, G., Fiorillo, C., Ricci, G., Greco, F., D'Amico, R. et al. Facioscapulohumeral muscular dystrophy: new insights from compound heterozygotes and implication for prenatal genetic counselling. J. Med. Genet. (2011).
9. Lemmers, R. J. L. F., van der Wielen, M., Bakker, E. & van der Maarel, S. Molecular diagnosis of FSHD. in FSHD Facioscapulohumeral Muscular Dystrophy: Clinical Medicine and Molecular Cell Biology. Upadhyaya, M. & Cooper, D. N. (eds) 211-234 (BIOS Scientific Publishers, New York, NY, 2004).
10. Goto, K., Nishino, I. & Hayashi, Y. K. Rapid and accurate diagnosis of facioscapulohumeral muscular dystrophy. Neuromuscul. Disord. 16, 256-261 (2006).
11. Nguyen, K., Walrafen, P., Bernard, R., Attarian, S., Chaix, C., Vovan, C. et al. Molecular combing reveals allelic combinations in facioscapulohumeral dystrophy. Ann. Neurol. 70, 627-633 (2011).
12. Fitzsimons, R. B. Retinal vascular disease and the pathogenesis of facioscapulohumeral muscular dystrophy. A signalling message from Wnt? Neuromuscul. Disord. 21, 263-271 (2011).
13. Goto, K., Lee, J. H., Matsuda, C., Hirabayashi, K., Kojo, T., Nakamura, A. et al. DNA rearrangements in Japanese facioscapulohumeral muscular dystrophy patients: clinical correlations. Neuromuscul. Disord. 5, 201-208 (1995).
14. Dorobek, M. & Kabzinska, D. A severe case of facioscapulohumeral muscular dystrophy (FSHD) with some uncommon clinical features and a short 4q35 fragment. Eur. J. Paediatr. Neurol. 8, 313-316 (2004).
15. Tsuji, M., Kinoshita, M., Imai, Y., Kawamoto, M. & Kohara, N. Facioscapulohumeral muscular dystrophy presenting with hypertrophic cardiomyopathy: a case study. Neuromuscul. Disord. 19, 140-142 (2009).
16. Wohlgemuth, M., van der Kooi, E. L., van Kesteren, R. G., van der Maarel, S. M. & Padberg, G. W. Ventilatory support in facioscapulohumeral muscular dystrophy. Neurology 63, 176-178 (2004).
17. Carter, G. T. & Bird, T. D. Ventilatory support in facioscapulohumeral muscular dystrophy. Neurology 64, 401 (2005).
18. Saito, A., Higuchi, I., Nakagawa, M., Saito, M., Uchida, Y., Inose, M. et al. An overexpression of fibroblast growth factor (FGF) and FGF receptor 4 in a severe clinical phenotype of facioscapulohumeral muscular dystrophy. Muscle Nerve 23, 490-497 (2000).
19. Balatsouras, D. G., Korres, S., Manta, P., Panousopoulou, A. & Vassilopoulos, D. Cochlear function in facioscapulohumeral muscular dystrophy. Otol. Neurotol. 28, 7-10 (2007).
20. Matsuzaka, T., Sakuragawa, N., Terasawa, K. & Kuwabara, H. Facioscapulohumeral dystrophy associated with mental retardation, hearing loss, and tortuosity of retinal arterioles. J. Child Neurol. 1, 218-223 (1986).
21. Ehrlich, M. Exploring hypotheses about the molecular etiology of FSHD: loss of heterochromatin spreading and other long-range interaction models. in FSHD Facioscapulohumeral Muscular Dystrophy: Molecular Cell Biology & Clinical Medicine. Cooper, D. N. & Upadhyaya, M. (eds) 253-276 (BIOS Scientific Pub, New York, NY, 2004).
22. van der Maarel, S. M., Frants, R. R. & Padberg, G. W. Facioscapulohumeral muscular dystrophy. Biochim. Biophys. Acta 1772, 186-194 (2007).
23. Alexiadis, V., Ballestas, M. E., Sanchez, C., Winokur, S., Vedanarayanan, V., Warren, M. et al. RNAPol-ChIP analysis of transcription from FSHD-linked tandem repeats and satellite DNA. Biochem. Biophys. Acta (1769) 29-40, 2007.
24. Gabellini, D., Green, M. R. & Tupler, R. Inappropriate gene activation in FSHD: a repressor complex binds a chromosomal repeat deleted in dystrophic muscle. Cell 110, 339-348 (2002).
25. Jiang, G., Yang, F., van Overveld, P. G., Vedanarayanan, V., van der Maarel, S. & Ehrlich, M. Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q. Hum. Mol. Genet. 12, 2909-2921 (2003).
26. Gabriels, J., Beckers, M. C., Ding, H., De Vriese, A., Plaisance, S., van der Maarel, S. M. et al. Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3kb element. Gene 236, 25-32 (1999).
27. Dixit, M., Ansseau, E., Tassin, A., Winokur, S., Shi, R., Qian, H. et al. DUX4, a candidate gene of facioscapulohumeral muscular dystrophy, encodes a transcriptional activator of PITX1. Proc. Natl Acad. Sci. USA 104, 18157-18162 (2007).
28. Bosnakovski, D., Lamb, S., Simsek, T., Xu, Z., Belayew, A., Perlingeiro, R. et al. DUX4c, an FSHD candidate gene, interferes with myogenic regulators and abolishes myoblast differentiation. Exp. Neurol. 214, 87-96 (2008).
29. Wuebbles, R. D., Hanel, M. L. & Jones, P. L. F. S. H. D. region gene 1 (FRG1) is crucial for angiogenesis linking FRG1 to facioscapulohumeral muscular dystrophy-associated vasculopathy. Dis. Model Mech. 2, 267-274 (2009).
30. Klooster, R., Straasheijm, K., Shah, B., Sowden, J., Frants, R., Thornton, C. et al. Comprehensive expression analysis of FSHD candidate genes at the mRNA and protein level. Eur. J Hum. Genet. 17, 1615-1624 (2009).
31. Winokur, S. T., Chen, Y. W., Masny, P. S., Martin, J. H., Ehmsen, J. T., Tapscott, S. J. et al. Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation. Hum. Mol. Genet. 12, 2895-2907 (2003).
32. Osborne, R. J., Welle, S., Venance, S. L., Thornton, C. A. & Tawil, R. Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy. Neurology 68, 569-577 (2007).
33. Lemmers, R. J., Wohlgemuth, M., van der Gaag, K. J., van der Vliet, P. J., van Teijlingen, C. M., de Knijff, P. et al. Specific sequence variations within the 4q35 region are associated with facioscapulohumeral muscular dystrophy. Am. J. Hum. Genet. 81, 884-894 (2007).
34. Tsumagari, K., Chen, D., Hackman, J. R., Bossler, A. D. & Ehrlich, M. FSH dystrophy and a subtelomeric 4q haplotype: a new assay and associations with disease. J Med. Genet. 47, 745-751 (2010).
35. Spurlock, G., Jim, H. P. & Upadhyaya, M. Confirmation that the specific SSLP microsatellite allele 4qA161 segregates with fascioscapulohumeral muscular dystrophy (FSHD) in a cohort of multiplex and simplex FSHD families. Muscle Nerve 42, 820-821 (2010).
36. Leidenroth, A. & Hewitt, J. E. A family history of DUX4: phylogenetic analysis of DUXA, B, C and Duxbl reveals the ancestral DUX gene. BMC Evol. Biol. 10, 364 (2010).
37. Tupler, R., Berardinelli, A., Barbierato, L., Frants, R., Hewitt, J. E., Lanzi, G. et al. Monosomy of distal 4q does not cause facioscapulohumeral muscular dystrophy. J. Med. Genet. 33, 366-370 (1996).
38. Xu, X., Tsumagari, K., Sowden, J., Tawil, R., Boyle, A. P., Song, L. et al. DNaseI hypersensitivity at gene-poor, FSH dystrophy-linked 4q35.2. Nucleic Acids Res. 37, 7381-7393 (2009).
39. de Greef, J. C., Lemmers, R. J., van Engelen, B. G., Sacconi, S., Venance, S. L., Frants, R. R. et al. Common epigenetic changes of D4Z4 in contraction-dependent and contraction-independent FSHD. Hum. Mutat. 30, 1-11 (2009).
40. Yamanaka, G., Goto, K., Ishihara, T., Oya, Y., Miyajima, T., Hoshika, A. et al. FSHDlike patients without 4q35 deletion. J Neurol. Sci. 219, 89-93 (2004).
41. Leidenroth, A., Sorte, H. S., Gilfillan, G., Ehrlich, M., Lyle, R. & Hewitt, J. E. Diagnosis by sequencing: correction of misdiagnosis from FSHD2 to LGMD2A by whole-exome analysis. Eur. J Hum. Genet. 20, 999-1003 (2012).
42. Snider, L., Asawachaicharn, A., Tyler, A. E., Geng, L. N., Petek, L. M., Maves, L. et al. RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophy. Hum. Mol. Genet. 18, 2414-2430 (2009).
43. Mattick, J. S. & Makunin, I. V. Non-coding RNA. Hum. Mol. Genet. 15(Spec No 1), R17-R29 (2006).
44. Mosch, K., Franz, H., Soeroes, S., Singh, P. B. & Fischle, W. HP1 recruits activity-dependent neuroprotective protein to H3K9me3 marked pericentromeric heterochromatin for silencing of major satellite repeats. PLoS One 6, e15894 (2011).
45. Szpakowski, S., Sun, X., Lage, J. M., Dyer, A., Rubinstein, J., Kowalski, D. et al. Loss of epigenetic silencing in tumors preferentially affects primate-specific retroelements. Gene 448, 151-167 (2009).
46. Zeng, W., de Greef, J. C., Chen, Y. Y., Chien, R., Kong, X., Gregson, H. C. et al. Specific loss of histone H3 lysine 9 trimethylation and HP1gamma/cohesin binding at D4Z4 repeats is associated with facioscapulohumeral dystrophy (FSHD). PLoS Genet. 5, e1000559 (2009).
47. Tsien, F., Sun, B., Hopkins, N. E., Vedanarayanan, V., Figlewicz, D., Winokur, S. et al. Hypermethylation of the FSHD syndrome-linked subtelomeric repeat in normal and FSHD cells but not in ICF syndrome cells. Molec. Gen. Metab. 74, 322-331 (2001).
48. de Greef, J. C., Wohlgemuth, M., Chan, O. A., Hansson, K. B., Smeets, D., Frants, R. R. et al. Hypomethylation is restricted to the D4Z4 repeat array in phenotypic FSHD. Neurology 69, 1018-1026 (2007).
49. Lyle, R., Wright, T. J., Clark, L. N. & Hewitt, J. E. The FSHD-associated repeat, D4Z4, is a member of a dispersed family of homeobox-containing repeats, subsets of which are clustered on the short arms of the acrocentric chromosomes. Genomics 28, 389-397 (1995).
50. Winokur, S. T., Bengtsson, U., Vargas, J. C., Wasmuth, J. J., Altherr, M. R., Weiffenbach, B. et al. The evolutionary distribution and structural organization of the homeobox-containing repeat D4Z4 indicates a functional role for the ancestral copy in the FSHD region. Hum. Mol. Genet. 5, 1567-1575 (1996).
51. Foronda, D., de Navas, L. F., Garaulet, D. L. & Sanchez-Herrero, E. Function and specificity of Hox genes. Int. J. Dev. Biol. 53, 1404-1419 (2009).
52. Richards, M., Coppee, F., Thomas, N., Belayew, A. & Upadhyaya, M. Facioscapulohumeral muscular dystrophy (FSHD): an enigma unravelled? Hum. Genet. 131, 325-340 (2011).
53. Tsumagari, K., Chang, S.-C., Lacey, M., Baribault, C., Chittur, S. V., Sowden, J. et al. Gene expression during normal and FSHD myogenesis. BMC Med. Genomics 4, 67 (2011).
54. Wood-Allum, C., Brennan, P., Hewitt, M., Lowe, J., Tyfield, L. & Wills, A. Clinical and histopathological heterogeneity in patients with 4q35 facioscapulohumeral muscular dystrophy (FSHD). Neuropathol. Appl. Neurobiol. 30, 188-191 (2004).
55. Reed, P., Porter, N. C., Strong, J., Pumplin, D. W., Corse, A. M., Luther, P. W. et al. Sarcolemmal reorganization in facioscapulohumeral muscular dystrophy. Ann. Neurol. 59, 289-297 (2006).
56. Carosio, S., Berardinelli, M. G., Aucello, M. & Musaro, A. Impact of ageing on muscle cell regeneration. Ageing Res. Rev. 10, 35-42 (2011).
57. Charge, S. B. & Rudnicki, M. A. Cellular and molecular regulation of muscle regeneration. Physiol. Rev. 84, 209-238 (2004).
58. Scharner, J. & Zammit, P. S. The muscle satellite cell at 50: the formative years. Skelet. Muscle 1, 28 (2011).
59. Bosnakovski, D., Xu, Z., Gang, E. J., Galindo, C. L., Liu, M., Simsek, T. et al. An isogenetic myoblast expression screen identifies DUX4-mediated FSHD-associated molecular pathologies. EMBO J. 27, 2766-2779 (2008).
60. Homma, S., Chen, J. C., Rahimov, F., Beermann, M. L., Hanger, K., Bibat, G. M. et al. A unique library of myogenic cells from facioscapulohumeral muscular dystrophy subjects and unaffected relatives: family, disease and cell function. Eur. J. Hum. Genet. 20, 204-210 (2011).
61. Geng, L. N., Yao, Z., Snider, L., Fong, A. P., Cech, J. N., Young, J. M. et al. DUX4 activates germline genes, retroelements, and immune mediators: Implications for facioscapulohumeral dystrophy. Dev. Cell 22, 38-51 (2012).
62. Wallace, L. M., Garwick, S. E., Mei, W., Belayew, A., Coppee, F., Ladner, K. J. et al. DUX4, a candidate gene for facioscapulohumeral muscular dystrophy, causes p53-dependent myopathy in vivo. Ann. Neurol. 69, 540-552 (2011).
63. Vanderplanck, C., Ansseau, E., Charron, S., Stricwant, N., Tassin, A., Laoudj-Chenivesse, D. et al. The FSHD atrophic myotube phenotype is caused by DUX4 expression. PLoS One 6, e26820 (2011).
64. Carter, M. G., Stagg, C. A., Falco, G., Yoshikawa, T., Bassey, U. C., Aiba, K. et al. An in situ hybridization-based screen for heterogeneously expressed genes in mouse ES cells. Gene. Expr. Patterns 8, 181-198 (2008).
65. Kobayashi, T. & Kageyama, R. Hes1 regulates embryonic stem cell differentiation by suppressing Notch signaling. Genes Cells 15, 689-698 (2010).
66. Suzuki, N., Furusawa, C. & Kaneko, K. Oscillatory protein expression dynamics endows stem cells with robust differentiation potential. PLoS One 6, e27232 (2011).
67. Falco, G., Lee, S. L., Stanghellini, I., Bassey, U. C., Hamatani, T. & Ko, M. S. Zscan4: a novel gene expressed exclusively in late 2-cell embryos and embryonic stem cells. Dev. Biol. 307, 539-550 (2007).
68. Tanaka, T. S. Transcriptional heterogeneity in mouse embryonic stem cells. Reprod. Fertil. Dev. 21, 67-75 (2009).
69. Tupler, R., Perini, G., Pellegrino, M. A. & Green, M. R. Profound misregulation of muscle-specific gene expression in facioscapulohumeral muscular dystrophy. Proc. Natl Acad. Sci. USA 96, 12650-12654 (1999).
70. Celegato, B., Capitanio, D., Pescatori, M., Romualdi, C., Pacchioni, B., Cagnin, S. et al. Parallel protein and transcript profiles of FSHD patient muscles correlate to the D4Z4 arrangement and reveal a common impairment of slow to fast fibre differentiation and a general deregulation of MyoD-dependent genes. Proteomics 6, 5303-5321 (2006).
71. Arashiro, P., Eisenberg, I., Kho, A. T., Cerqueira, A. M., Canovas, M., Silva, H. C. et al. Transcriptional regulation differs in affected facioscapulohumeral muscular dystrophy patients compared to asymptomatic related carriers. Proc. Natl Acad. Sci. USA 106, 6220-6225 (2009).
72. Cheli, S., Francois, S., Bodega, B., Ferrari, F., Tenedini, E., Roncaglia, E. et al. Expression profiling of FSHD-1 and FSHD-2 cells during myogenic differentiation evidences common and distinctive gene dysregulation patterns. PLoS One 6, e20966 (2011).
73. Fitzsimons, R. B. Facioscapulohumeral dystrophy: the role of inflammation. Lancet 344, 902-903 (1994).
74. Arahata, K., Ishihara, T., Fukunaga, H., Orimo, S., Lee, J. H., Goto, K. et al. Inflammatory response in facioscapulohumeral muscular dystrophy (FSHD): immunocytochemical and genetic analyses. Muscle Nerve 2, S56-S66 (1995).
75. Kan, H. E., Scheenen, T. W., Wohlgemuth, M., Klomp, D. W., van Loosbroek-Wagenmans, I., Padberg, G. W. et al. Quantitative MR imaging of individual muscle involvement in facioscapulohumeral muscular dystrophy. Neuromuscul. Disord. 19, 357-362 (2009).
76. Frisullo, G., Frusciante, R., Nociti, V., Tasca, G., Renna, R., Iorio, R. et al. CD8 (+) T Cells infacioscapulohumeral muscular dystrophy patients with inflammatory features at muscle MRI. J. Clin. Immunol. 31, 155-166 (2011).
77. Sun, G., Haginoya, K., Wu, Y., Chiba, Y., Nakanishi, T., Onuma, A. et al. Connective tissue growth factor is overexpressed in muscles of human muscular dystrophy. J. Neurol. Sci. 267, 48-56 (2008).
78. Laoudj-Chenivesse, D., Carnac, G., Bisbal, C., Hugon, G., Bouillot, S., Desnuelle, C. et al. Increased levels of adenine nucleotide translocator 1 protein and response to oxidative stress are early events in facioscapulohumeral muscular dystrophy muscle. J. Mol. Med. 83, 216-224 (2005).
79. Hirata, T., Amano, T., Nakatake, Y., Amano, M., Piao, Y., Hoang, H. G. et al. Zscan4 transiently reactivates early embryonic genes during the generation of induced pluripotent stem cells. Sci. Rep. 2, 208 (2012).
80. Hryniuk, A., Grainger, S., Savory, J. G. & Lohnes, D. Cdx function is required for maintenance of intestinal identity in the adult. Dev. Biol. 363, 426-437 (2012).
81. Gundersen, K. Excitation-transcription coupling in skeletal muscle: the molecular pathways of exercise. Biol. Rev. Camb. Philos. Soc. 86, 564-600 (2011).
82. Barber, B. A. & Rastegar, M. Epigenetic control of Hox genes during neurogenesis, development, and disease. Ann. Anat. 192, 261-274 (2010).
83. Soshnikova, N. & Duboule, D. Epigenetic regulation of vertebrate Hox genes: a dynamic equilibrium. Epigenetics 4, 537-540 (2009).
84. MacLean, 2nd J. A. & Wilkinson, M. F. The Rhox genes. Reproduction 140, 195-213 (2010).
85. Li, J., Dani, J. A. & Le, W. The role of transcription factor Pitx3 in dopamine neuron development and Parkinson's disease. Curr. Top Med. Chem. 9, 855-859 (2009).
86. Lepper, C., Conway, S. J. & Fan, C. M. Adult satellite cells and embryonic muscle progenitors have distinct genetic requirements. Nature 460, 627-631 (2009).
87. Tschopp, P. & Duboule, D. A genetic approach to the transcriptional regulation of Hox gene clusters. Annu. Rev. Genet. 45, 145-166 (2011).
88. Boutet, S. C., Biressi, S., Iori, K., Natu, V. & Rando, T. A. Taf1 regulates Pax3 protein by monoubiquitination in skeletal muscle progenitors. Mol. Cell 40, 749-761 (2010).
89. Chen, J. F., Tao, Y., Li, J., Deng, Z., Yan, Z., Xiao, X. et al. microRNA-1 and microRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7. J. Cell. Biol. 190, 867-879 (2010).
90. Liu, D. X. & Lobie, P. E. Transcriptional activation of p53 by Pitx1. Cell Death Differ. 14, 1893-1907 (2007).
91. Daftary, G. S. & Taylor, H. S. Endocrine regulation of HOX genes. Endocr. Rev. 27, 331-355 (2006).
92. Mann, R. S., Lelli, K. M. & Joshi, R. Hox specificity unique roles for cofactors and collaborators. Curr. Top Dev. Biol. 88, 63-101 (2009).
93. Mallo, M., Wellik, D. M. & Deschamps, J. Hox genes and regional patterning of the vertebrate body plan. Dev. Biol. 344, 7-15 (2010).
94. Clapp, J., Mitchell, L. M., Bolland, D. J., Fantes, J., Corcoran, A. E., Scotting, P. J. et al. Evolutionary conservation of a coding function for D4Z4, the tandem DNA repeat mutated in facioscapulohumeral muscular dystrophy. Am. J. Hum. Genet. 81, 264-279 (2007).
95. Wu, S. L., Tsai, M. S., Wong, S. H., Hsieh-Li, H. M., Tsai, T. S., Chang, W. T. et al. Characterization of genomic structures and expression profiles of three tandem repeats of a mouse double homeobox gene: Duxbl. Dev. Dyn. 239, 927-940 (2010).
96. Kawazu, M., Yamamoto, G., Yoshimi, M., Yamamoto, K., Asai, T., Ichikawa, M. et al. Expression profiling of immature thymocytes revealed a novel homeobox gene that regulates double-negative thymocyte development. J. Immunol. 179, 5335-5345 (2007).
97. Barro, M., Carnac, G., Flavier, S., Mercier, J., Vassetzky, Y. & Laoudj-Chenivesse, D. Myoblasts from affected and non affected FSHD muscles exhibit morphological differentiation defects. J. Cell Mol. Med. 275-289 (2010).
98. Baumer, N., Sandstede, M. L., Diederichs, S., Kohler, G., Readhead, C., Ji, P. et al. Analysis of the genetic interactions between Cyclin A1, Atm and p53 during spermatogenesis. Asian J. Androl. 9, 739-750 (2007).
99. Bentzinger, C. F., von Maltzahn, J. & Rudnicki, M. A. Extrinsic regulation of satellite cell specification. Stem Cell Res. Ther. 1, 27 (2011).
100. Kirkpatrick, L. J., Yablonka-Reuveni, Z. & Rosser, B. W. Retention of Pax3 expression in satellite cells of muscle spindles. J. Histochem. Cytochem. 58, 317-327 (2010).